Zeev Bronfeld, Director, 10% Owner at Protalix BioTherapeutics, Inc. (PLX), sold 4,400,000 shares at $2.47 ($10.9M) on 2014-08-13, disclosed to the SEC on 2014-08-15.
Open-market sale of $10.9M PLX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GEYI | BUY | 2007-05-04 | $300K | — | Filing → |